↓ Skip to main content

Dove Medical Press

Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers

Overview of attention for article published in Drug Design, Development and Therapy, December 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
patent
7 patents

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
61 Mendeley
Title
Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers
Published in
Drug Design, Development and Therapy, December 2014
DOI 10.2147/dddt.s72572
Pubmed ID
Authors

Corrado Blandizzi, Giuseppe Claudio Viscomi, Carmelo Scarpignato

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 61 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 16%
Student > Ph. D. Student 8 13%
Researcher 6 10%
Other 5 8%
Student > Bachelor 4 7%
Other 13 21%
Unknown 15 25%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 17 28%
Chemistry 11 18%
Medicine and Dentistry 5 8%
Physics and Astronomy 2 3%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 6 10%
Unknown 18 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 December 2021.
All research outputs
#2,202,171
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#110
of 2,268 outputs
Outputs of similar age
#29,445
of 369,146 outputs
Outputs of similar age from Drug Design, Development and Therapy
#4
of 48 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,146 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.